HIVpxresearch Profile Banner
AVAC Profile
AVAC

@HIVpxresearch

Followers
16K
Following
10K
Media
5K
Statuses
22K

Proven strategies for today and research for tomorrow. A global source for updates, advocacy and information on HIV prevention.

New York, USA
Joined April 2010
Don't wanna be here? Send us removal request.
@HIVpxresearch
AVAC
8 months
@imglobalhealth @KFF @jenkatesdc @Srj_Madoori Given the increasing and alarming rise of misinformation on X, it is essential we find new ways to share accurate, science-based information. AVAC is beginning our transition to the platform Bluesky. 🦋 Make sure to follow us there!
Tweet media one
0
1
12
@HIVpxresearch
AVAC
13 days
RT @devex: Despite the changes in the global health funding landscape, AVAC (@HIVpxresearch) Executive Director Mitchell Warren highlights….
0
1
0
@HIVpxresearch
AVAC
6 months
RT @mdoherty_hiv: Prevention is needed to #ENDAIDS .Freeze on global HIV prevention efforts sparks disbelief, anger | Science | AAAS https….
Tweet card summary image
science.org
After chaotic halt, PEPFAR’s global distribution of HIV treatments may be resuming but limits on using drugs to curb viral spread remain
0
13
0
@HIVpxresearch
AVAC
7 months
RT @Bhekisisa_MG: #DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R14….
0
2
0
@HIVpxresearch
AVAC
7 months
One of the biggest news items of 2024 was the incredible effectiveness of injectable lenacapavir for #HIV prevention. But can the world translate this science into public health impact? Our Mitchell Warren and @JRatevosian think so — and explain how in this @devex commentary 👇.
@devex
Devex
7 months
There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.
2
2
11
@HIVpxresearch
AVAC
7 months
From the implementation of #DoxyPEP, to the trial results of #LEN for #PrEP, there have been major strides in #HIV and #STI prevention in 2024. AVAC’s resources track it all to inform your advocacy. See our top 🔟 most downloaded resources of 2024 at
Tweet media one
Tweet media two
1
6
10
@HIVpxresearch
AVAC
7 months
Among his many contributions, #JimmyCarter was a pioneer in global health. A great summary from @snolen: — with this essential lesson for @melindagates
Tweet media one
1
0
6
@HIVpxresearch
AVAC
7 months
2024 has been full of rich and invigorating conversations on our podcast #PxPulse, ranging on topics such as LGBTQ+ rights in Uganda, choice and #HIV prevention, how the US election impacts public health and more. Join us for a season of listening at 🎧
Tweet media one
1
2
14
@HIVpxresearch
AVAC
7 months
Advocating for #PrEP with speed, scale and equity will be an essential part of our work in 2025. Kick-off the year by bookmarking #PrEPWatch for the latest in research & development (R&D), implementation and #PrEP initiations worldwide. 🌐 Explore more at
Tweet media one
0
9
19
@HIVpxresearch
AVAC
7 months
Throughout 2024, we have seen rising rates of #syphilis globally. 🌐 Explore #STIWatch to learn the latest about #STI vaccine and diagnostic R&D for syphilis and other STIs.
Tweet media one
1
11
19
@HIVpxresearch
AVAC
7 months
RT @Bhekisisa_MG: #DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R14….
0
1
0
@HIVpxresearch
AVAC
7 months
An op-ed on the potential of #LEN penned by AVAC's executive director Mitchell Warren and @JRatevosian in @devex, Gilead plans to halt free access to #HIV drug, worrying advocates, and more in the final #NewsDigest of 2024. 📰 Read on and subscribe!
Tweet media one
0
0
8
@HIVpxresearch
AVAC
7 months
Positive steps toward rolling #LEN for #PrEP out with speed, scale & equity, but more more needs to happen. ICYMI, @GileadSciences filed to US FDA and @PEPFAR & @GlobalFund announced a coordinated effort to reach 2M people with access to LEN. Read more:
Tweet media one
0
8
20
@HIVpxresearch
AVAC
7 months
RT @CarlosdelRio7: .@GileadSciences Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV….
0
20
0
@HIVpxresearch
AVAC
7 months
RT @HIVpxresearch: Just released! 💥 #LEN, the twice-yearly injectable #PrEP has the potential to transform the #HIV response, but only if i….
0
4
0
@HIVpxresearch
AVAC
7 months
Just released! 💥 #LEN, the twice-yearly injectable #PrEP has the potential to transform the #HIV response, but only if it is rolled out with speed, scale and equity. Read the latest op-ed from AVAC’s ED Mitchell Warren and @JRatevosian in @devex.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
4
9
@HIVpxresearch
AVAC
7 months
RT @Acts101U: Join us tonight as we assess 40 years of HIV response for Uganda, the challenges we have encountered and how we can do better….
0
7
0
@HIVpxresearch
AVAC
7 months
With the future of prevention products, it's important we consider all populations and their needs to ensure that choice is paramount in the roll out of these products.
Tweet media one
0
0
1
@HIVpxresearch
AVAC
7 months
@DukeU_Nursing Tonia Poteat of @DukeU_Nursing shares the important role peer navigators (PN) played in #HPTN091 including not only sharing information but resources (i.e. name changes, food stamps etc.). A sound bite from one of the PNs: "Together we are stronger than we imagine".
Tweet media one
1
0
4
@HIVpxresearch
AVAC
7 months
"Randomization works" 🎯 Tonia Poteat of @DukeU_Nursing breaks down the diverse characteristics of people enrolled in #HPTN091 and how important it was to include participants that would benefit most from #PrEP.
Tweet media one
1
0
1
@HIVpxresearch
AVAC
7 months
@DukeU_Nursing @HIVptn Tonia Poteat of @DukeU_Nursing discusses the real challenges trans people face when finding a service provider they trust. This challenge impacted how participated in #HPTN091. More below ⤵️
Tweet media one
1
0
1